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Abstract
When small B lymphocytes bind their cognate antigens in the context of suitable signals, a dramatic differentiation program is activated that
leads to the formation of plasma cells. These are short-lived specialized elements, each capable of secreting several thousands antibodies per
second. The massive increase in Ig synthesis and transport entails a dramatic architectural and functional metamorphosis that involves the
development of the endoplasmic reticulum (ER) and secretory organelles. Massive Ig secretion poses novel metabolic requirements, particularly
for what concerns aminoacid import, ATP synthesis and redox homeostasis. Ig H and L chains enter the ER in the reduced state, to be rapidly
oxidised mainly via protein driven relays based on the resident enzymes PDI and Ero1. How do plasma cells cope with the ensuing metabolic and
redox stresses? In this essay, we discuss the physiological implications that increased Ig production could have in the control of plasma cell
generation, function and lifespan, with emphasis on the potential role of ROS generation in mitochondria and ER.
© 2008 Elsevier B.V. All rights reserved.Keywords: Oxidative folding; Plasma cells; Differentiation; Oxidative stress; Apoptosis; Antibody secretion1. Introduction
In histology textbooks, exocrine pancreas or plasma cells are
often selected as prototypic examples to illustrate the morphology
of cells specialized in protein secretion (professional secretory
cells). The most striking common feature is a highly developed
rough ER, which occupies the majority of the cytoplasm. This
comes as no surprise, since the ER is the site of production of
proteins destined to the extracellular world. These include
soluble proteins released as ligands, membrane molecules en-
dowed with receptor, channel or transporter activities and re-
sident proteins of the exocytic pathway. The ionic and redox
conditions found in the ER and downstream organelles re-
semble those encountered in the extracellular space (higherAbbreviations: ASC, Antibody Secreting Cells; BCR, B Cell Receptor; ER,
endoplasmic reticulum; Ero1, ER Oxidoreductin 1; PDI, Protein Disulfide
Isomerase; Ig, Immunoglobulin
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suitable conditions for secretory proteins – a term herein used
to refer to proteins synthesized on ER bound ribosomes – to
attain their three-dimensional structure. It also provides a test
bench to ensure that ligands and receptors attain the very con-
formation that allows the proper signals to be transmitted and
deciphered. Indeed, folding and assembly are intimately cou-
pled to a stringent quality control schedule that restricts tran-
sport along the secretory route to native molecules [1,2].
Whilst the basic principles of folding are the same in all cell
compartments, secretory proteins undergo unique covalent modi-
fications, i.e. cleavage of the signal sequences, N-glycosylation,
GPI additions and disulfide bond formation. These are catalyzed
by a sophisticated network of specialized chaperones and en-
zymes spatially distributed along the various stations of the exo-
cytic route, providing the most efficient assembly, quality control
and transport line [1–3].
How is this assembly line built and operated? How do cells
adapt their size to the synthetic demands? How do they keep track
of the various activities ongoing in different compartments? These
key questions are beginning to be understood and some of the
underlying signalling pathways unveiled.
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factories” [4–6] upon activation with antigen or mitogens pro-
vides a suitable system to analyse the molecular mechanisms
that bring to the development of a professional secretory cell.
Primary B cells and certain B lymphoma lines can be readily
induced to undergo a real metamorphosis finalised to achieve
massive antibody production. The high rate of protein synthesis
and secretion achieved by plasma cells requires dealing with
different kinds of stresses, as it demands metabolites and energy
production, as well as the disposal of numerous catabolites, in
large amounts. Physiologically, other features make B cell dif-
ferentiation a unique and challenging model system. The regu-
lation of antibody responses (proliferation of antigen specific
clones, generation of memory cells, affinity maturation, etc.) is
a very fascinating problem that involves the generation and
interactions of a vast number of highly specialized subpopula-
tions [4,7,8]. Suffice here to summarize a few features of the
process to introduce the redox problems that terminal B cell
differentiation entails. Peripheral lymphoid organs are popu-
lated by long-lived B cells, each expressing a receptor specific
for a given antigen (the BCR). B cells should not secrete anti-
bodies before they encounter their cognate antigen, as these
might compete with BCRs for antigen binding. Preferential
splicing toward the membrane form of heavy chains limits
secretion. In the case of IgM, the isotype that dominates primary
responses, post-translational events are also active. Owing to
the inability of B cells to polymerize IgM, intermediates are
retained and eventually degraded by thiol-dependent mechan-
isms [9]. Soon after the proper signal is delivered, however,
some B cells must rapidly differentiate and release antibodies so
as to combat the incoming enemy. Synthesis of Ig subunits
increases, and redox changes ensue that allow IgM polymeriza-
tion and secretion. To limit the immune response, most
Antibody Secreting Cells (ASC) cells die after a few days of
intense immunoglobulin production. A few of them home in the
bone marrow and survive for longer periods, maintaining
sufficient antibody titres to protect against re-infection [7].
Intriguing questions remain largely unanswered on the
mechanisms involved in regulating plasma cell apoptosis, and
the differences between long and short-lived ones.
In line with their physiological role of cells of the B lineage,
the early phases of B cell development are regulated by sig-
nalling pathways based on the capability of assembling func-
tional BCRs [10,11]. Along the same lines, it is tempting to
speculate that the terminal plasma cell differentiation also obeys
the same rules, and devoted sensors exist that keep track of
the type and quantity of antibody produced. How can a cell
remember the number of molecules it had secreted? We have
recently shown that as Ig production increases upon B cell
differentiation, the proteasomal capacity decreases. As a result,
polyubiquitinated proteins increase, and certain proteins
normally degraded by proteasomes (i.e. IκBα, Bax and Bim)
are stabilised. The process is accompanied by increased
sensitivity to proteasome inhibitors and spontaneous apoptosis
[12]. If an increased proteasomal load vs capacity ratio
predisposes ASC to apoptosis, the nature of the final blow
remains to be determined [13]. Among other factors, reactiveoxygen species (ROS) production could be an important source
of signals (and stress) for plasma cells. Recent evidences prove
that the process of oxidative folding can generate ROS [14–17].
These molecules are generally associated with cell damaging
events, senescence and death. A new exciting field is emerging
though, that recognizes ROS as second messenger molecules,
able to produce rapid and reversible post-translational mod-
ifications on proteins similar to phosphorylation. Indeed more
and more findings indicate that ROS, in particular H2O2, are
essential to the proper development and proliferation of cells
[18–22]. Intriguingly, a role for H2O2 has been proposed for the
BCR [23]. Since Ig are rich in disulphide bonds, their increasing
production in differentiating B cells could generate ROS that
might act as signalling devices.
In this essay, we will review the available evidence on the
regulation of redox homeostasis during B to plasma cell dif-
ferentiation, and discuss possible models that may couple Ig
production to lifespan control.
2. Oxidative protein folding
Disulphide bonds are essential for the folding and assembly
of many proteins synthesized in the ER. They increase stabi-
lity, an important feature for Ig to recognize and neutralize
foreign elements in the body fluids [24]. Disulfide bond for-
mation is based on redox reactions in which two cysteines are
oxidised by removal of two electrons forming a covalent bond
[25]. Although direct oxidation could also take place, in living
cells oxidative folding utilizes primarily disulfide interchange
reactions in which an oxidised donor molecule (D) transfers
the bond to a reduced acceptor (A) via formation of a transient
mixed disulfide intermediate:
D‐SSþ HS‐A‐SHYHS‐D‐SS‐A‐SHYHS‐D‐SHþ A‐SS:
Cargo proteins enter reduced in the ER and are rapidly oxi-
dised by protein disulphide isomerase (PDI). PDI is then re-
oxidised by Ero1 flavoproteins (Fig. 1). Electrons are finally
transferred to molecular oxygen and possibly to other electron
acceptors, particularly in anaerobic conditions [14,16,26–30].
In yeast, Ero1p is an essential gene, whose expression is
induced in conditions of ER stress (see C. Kaiser and D. Fass
articles in this issue). Also PDI is essential in yeast, despite the
presence of numerous other oxidoreductases in the ER. The
forced expression of some of these can partially complement the
absence of PDI.
This pathway is fundamentally conserved in higher eukar-
yotes, although some important differences exist. First, whilst a
single Ero1 gene exists in Saccharomyces cerevisiae, two iso-
forms, Ero1α and Ero1β, are found inmammals. Both are able to
complement yeast ero1 mutants, underscoring the conservation
of the oxidative folding pathways. Ero1α is induced by hypoxia
[31] and PPARγ and inhibited by SIRT1 ([32] and references
therein). In contrast, Ero1β increases during the UPR [33], and is
constitutively expressed at high levels in certain secretory tissues
[34], confirming that ER stress responses are important for the
acquisition of the secretory phenotype [5,35,36]. The reasons
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Ero1β in mammals are not yet clear.
Another remarkable difference between yeast and mamma-
lian Ero1 molecules concerns the mechanisms of sub-cellular
localisation. A C-terminal tail is present in yEro1p that mediates
membrane association and is essential for function. Neither
Ero1α nor Ero1β possesses this tail. Both are secreted by
mammalian cells when over-expressed, implying saturable re-
tention mechanism(s). It was demonstrated that the localisation
of Ero1α and Ero1β depends on dynamic interactions with PDI
or ERp44 [37], two soluble proteins that despite the presence
of ER localisation motifs (KDEL and RDEL, respectively)
are differentially distributed in the early secretory pathway.
ERp44 accumulates in ERGIC and cis-Golgi, distally with
respect to PDI [38,39]. Of the three trx-like domains of ERp44,
only the N-terminal one possesses a catalytic CRFS motif. It
is via this cysteine that ERp44 forms mixed disulfides with
Ero1α, Ero1β, unpolymerized IgM subunits, adiponectin and
other substrates of thiol-dependent protein quality control [9,
32,39]. The differential distribution of PDI and ERp44 is im-
portant in the biogenesis of IgM polymers, dictating their step-
wise assembly and quality control and coupling efficiency and
fidelity in the antibody factory ([38]; see also below). The
dynamic retention of Ero1α may allow the oxidoreductin to
distribute in distinct subcompartments, and provide the oxi-
dative power needed in the sequential steps in IgM biogenesis
[38]. Moreover, it offers an elegant mechanism to regulate the
secretion of certain proteins; indeed, the over-expression of
Ero1α allows secretion of unassembled IgM [9] and adipo-
nectin [32,39] by competitive binding with ERp44, as well as
by favouring oxidation of the substrate proteins.
2.1. Regulating oxidative power in the ER
As recalled above, Ero1β is expressed in conditions of ER
stress, or in certain tissues specialised in protein secretion. A
mechanism can be hence envisaged that adjusts oxidative powerFig. 1. Oxidative folding and the generation of ROS. In eukaryotic cells, oxidative fol
PDI and Ero1 molecules. In vitro, yeast Ero1 is oxidised by molecular oxygen gen
mammalian cells express constitutively Ero1α. If cargo is produced in excess, Ero1in the ER. When Ero1α becomes insufficient, reduced proteins
would accumulate in the ER. The consequent UPR increases
Ero1β, thus generating the required oxidative power. However,
cells must also prevent over-oxidation. In the ER, disulphide
bonds must be constantly isomerised for many proteins to attain
their final three-dimensional structure. Furthermore, proteins that
fail to fold or assemble are not allowed to proceed along the
secretory pathway and inter-chain disulphide bonds are reduced
prior to their retro-translocation to the cytosol for degradation
[40–42]. Many PDI homologs reside in the ER of mammalian
cells (e.g. ERp57, ERp72, P5, PDIR, PDIp and ERp27) (see
L. Ellgaard in this issue, [43–45] and [33,46]). Since Ero1 mo-
lecules selectively interact with a subset of them [15,47], some
members could exert reductase activities. Recent results indicate
that ERdj5, an ER resident protein containing a DnaJ domain and
four thioredoxin-like domains, favours ER associated degradation
of certain substrate proteins reducing their inter-chain disul-
fide bonds (Nagata et al., personal communication). An exciting
question that emerges from these findings is what maintains
ERdj5 in the reduced state.
Despite the specificity of protein relays which allow opposite
redox reactions to coexist in the ER (disulfide bond formation in
nascent proteins, reduction in terminally misfolded ones), Ero1
activity must be nonetheless tightly controlled. Its main substrate,
PDI must remain in part reduced to act as an isomerase and as a
redox-sensitive chaperone, catalyzing ERAD substrate unfolding
before dislocation [48–50]. Moreover, elegant in vitro assays
demonstrated that Ero1p generates H2O2 in equimolar amounts to
the number of disulphide bonds formed [16]. H2O2 can be
converted to other ROS which can be highly detrimental for the
cell [22]. Suggestions of a significant contribution of Ero1 in
cellular ROS production in metazoans come from the observation
that down-regulation of Ero1 strongly reduces ROS levels in ER
stressed Caenorabditis elegans [51]. Since human Ero1α and β
can complement yeast defective cells, it would be extremely
important to determine whether oxidative folding generates
peroxide also in mammalian cells, and if so in what molar ratio.ding of cargo proteins is based on serial disulfide interchange reactions involving
erating H2O2 in stoichiometric amounts to the disulphide bonds formed. Most
β is induced via UPR pathways activated by inefficient oxidative folding.
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regulating Ero1p activity [29,45]. The oxidation of two non-
catalytic cysteine pairs, leads to inactivation of the enzyme. This
rapid feedback mechanism could be particularly important in
physiological situations when the requirements for oxidative
folding vary transiently and frequently, as in certain secretory
cells. The translocation of reduced substrates into the ER lumen
shifts the redox balance toward reducing conditions, and rapidly
activates pre-existing Ero1 molecules, thus fulfilling the
increased oxidative demand. If this pool proves insufficient,
the transcription of Ero1 (Ero1β in mammalian cells) is
induced. The two redox isoforms observed in human Ero1α
(Ox1 and Ox2) might correspond to distinct functional states
[27,52].
Another redox-sensitive feedback mechanism could operate
at the transcriptional level. Ero1α is regulated by the hypoxia-
inducible factor 1 (HIF1) [31]. The O2 sensing subunit of HIF1,
HIF1α, has been found at the ER where it is kept silent by O2-
dependent generation of •OH. The hydroxyl radical is
produced by an ER localised Fenton reaction [H2O2+Fe
2+→
Fe3++OH−+•OH] [53]. It is tempting to speculate that Ero1 is
the source of H2O2 production at the ER.
Mammalian Ero1α is generally expressed at rather low le-
vels in cultured cell lines and the assumption is that its catalytic
activity is enough to drive multiple PDI oxidation cycles and
hence ensure the folding of many substrate molecules. Low
expression would help in avoiding the risk of oxidative stress.
However, data concerning Ero1β suggest that this model is
maybe too simplistic. Ero1β is expressed at high levels in spe-
cific cell types of human stomach and pancreas. It can form
homo- and hetero-dimers with Ero1α. In vivo, the ratio between
Ero1β monomers and dimers differs in stomach and pancreas
[34]. Even though the biological meaning of Ero1 β homo- and
hetero-dimers is not clear, their tissue specific regulation hints to
a complex mode of control of Ero1 activity.
Besides the existence of Ero1-centered regulatory mechan-
isms, ER redox homeostasis heavily relies on a variety of cel-
lular buffering systems, including glutathione and NADP+/
NADPH (recently reviewed in [54]). The cellular concentration
of GSH ranges from 1 to 10 mM [55] but the ratio between
oxidised (GSSG) and reduced (GSH) species is very different in
the cytosol (1:30–100) and in the ER (1:1–3) [56,57]. This has
been long considered the driving force for disulphide bond
formation, but the discovery of the Ero1-PDI relays has changed
this point of view. It seems now clear that GSH is crucial in
balancing Ero1 function, avoiding ER hyper-oxidation and for-
mation of non-native disulphide bonds [58–60].
Like the GSH/GSSG couple, NAD+/NADH and NADP+/
NADPH have a pivotal role in protecting the cell against ROS
damage, being involved in the main anti-oxidant defence systems
comprising glutathione peroxidases (Gpx), the thioredoxin–
thioredoxin reductase system (Trx), peroxiredoxins (Prx), glu-
taredoxins, superoxide dismutases (SOD), catalases and exogen-
ousmicronutrients and vitamins [21,54]. Open questions concern
the mechanisms that drive the import of GSH, NADH and
NADPH into the ER lumen, and their regulation during dif-
ferentiation or stress.3. Redox-dependency of BCR activation
Many lines of evidence confirm that ROS play a direct role
in the development, survival and terminal differentiation of
mature B lymphocytes. These cells express surface BCR, a
complex formed by membrane Ig (in charge of recognizing
antigen) and the kinases Igα and Igβ, involved in signal
transduction (Fig. 2). BCR expression is indispensable for B
cell survival even in the absence of antigen, implying that basal
signals are generated and deciphered [61,62]. Signalling from
the BCR was demonstrated to involve ROS. Suitable doses of
H2O2 can mimic antigen binding and trigger the same
phosphorylation cascade as BCR cross-linking [23]. ROS
generation by the DUOX1 NADPH oxidase is critical for
BCR signalling upon antigen binding. Oxidants and Ca++ act in
a cooperative manner to regulate the strength and duration of
BCR signalling [63], crucial parameters for determining the
subtype of B cell generated from transitional, immature B cells
[64]. It is still unclear what the source of the basal BCR
signalling is and how the strength of the signals could be
achieved and interpreted. Binding of ligands (e.g. LPS) to Toll
like receptors (TLR) activates NAPDH oxidases [65,66] sug-
gesting a main role for superoxides as second messengers in the
activation of the innate and humoral immune responses. Upon
stimulation with LPS or INFγ, macrophages and dendritic cells
produce B-cell-activating factor (BAFF), essential for B cell
generation and maintenance. LPS-induced BAFF expression is
potentiated by ROS and inhibited by PrxII [67].
4. Preparing for antibody secretion
Increased demand for protein folding power in the ER trig-
gers the Unfolded Protein Response (UPR), a multidimensional
signalling pathway that regulates the expression of ER resident
proteins and lipids [36,68,69], translation, the cell cycle and apo-
ptosis [70–72]. Three resident membrane proteins, IRE1, ATF6
and PERK, sense ER stress. Not only is the response activated in
stress or disease: to achieve a high rate of protein synthesis and
transport, secretory cells utilize arms of the UPR. Interestingly,
they do so in a tissue specific way, suggesting subtle regulatory
pathways [5]. IRE1 and the downstream transcription factor
XBP1 are essential for plasma cell differentiation [35,73], whilst
PERK and CHOP ([74] and S. Masciarelli, L. Hendershot and R.
Sitia, unpublished results) are not. The role and regulation of the
UPR in B cell differentiation is matter of extensive discussion
[5,6,74]. The easiest model would predict that exuberant Ig
production triggers the UPR, thus favouring the expansion of the
ER and other secretory organelles [75–79]. However, studies on
in vitro differentiating B lymphoma cells showed that B cells
increase the transcription of UPR genes well before starting
massive Ig production [80,81], which implies additional cross-
talk(s) between differentiation signals and the UPR. A connection
seems to be provided by Blimp1, a transcription factor whose
expression is sufficient to induce plasma cell differentiation. In-
terestingly, the finding that XBP-1 is a target of Blimp1 [36],
provides an explanation as to how B cells can expand the sec-
retory pathway by selectively activating arm(s) of the UPR.
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Once the secretory route and metabolic supplies have been
sufficiently expanded, IgM production increases exponen-Fig. 2. B cell differentiation. Mature B lymphocytes are long-lived resting cells with s
specific B cell receptors (BCR) composed by themembrane-specific isoform of Ig (μm
μm chains possess a hydrophobic tail essential for membrane insertion and assemb
assembly, retention and degradation of unpolymerized secretory IgM subunits [14
sustained byH2O2 generation. After an initial phase of clonal expansion, differentiation
ER and other secretory organelles, together with empoweredmetabolic and synthetic c
driving ER expansion. The Blimp-1-dependent transcription of XBP-1 may provide
After a couple of days, ASC increase IgM synthesis, and polymerization and secretion
of intensive Ig secretion most ASC undergo apoptosis. Different types of stress (ERtially. The translational apparatus focuses on Ig-μ and L chains,
somehow resembling the situation encountered in virus infected
cells, and for a few days a differentiating B cell masters the
production and release of thousands of IgM per second. Ascarce cytosol that do not secrete antibodies. They express on their surface antigen
2L2). Membrane and secreted Ig-μ (μm and μs) differ in their C-terminal segments.
ly with BCR signalling components (Igα–Igβ). The μs tailpiece mediates the
9–152]. Antigen binding initiates a signalling cascade which is amplified and
entails an increase in the cell volume largely sustained by the development of the
apacities [80]. The ATF6 and Ire1 UPR arms are activated and likely contribute in
a further link between the UPR and the increase in secretory capacity of the cell.
ensue. ERp44 and ERGIC-53may promote polymerization [38]. After a few days
stress, proteotoxicity, redox imbalance) likely concur in causing cell death.
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cluding aminoacid import, energy production and redox balance.
To satisfy the increased demand for oxidative folding, more
Ero1α and β are produced. Also few proteins involved in redox
control, peroxiredoxin 4 (Prx4) and glutathione S-transferase
theta 2 increase in this phase. Interestingly, whilst Ero1α is
activated soon, with kinetics similar to other ER residents
(depicted in light blue in Fig. 3), Ero1 β increases in the last days
of differentiation, concomitantly with the onset of IgM
polymerization and massive release ([80,81] M. Otsu, S.
Masciarelli and R. Sitia, unpublished data). A similar temporal
expression pattern also characterizes ERp44 and ERGIC-53, two
proteins shown to facilitate IgM polymerization [38], as well as
Sel1L, a protein that in association with the E3 ligase Hrd1,
mediates the degradation of unassembled μ chains [82] (Cattaneo
et al., 2008). These observations possibly reflect the attempts to
optimize Ig assembly, quality control and release. It will be of
interest to identify additional proteins with similar kinetics, as
these could play an important role in the antibody factory.
6. Ending the antibody response
After a few days of intense Ig secretion most ASCs die [7].
Their short lifespan is probably important to limit the immune
response. If the antigen is not yet defeated, new specific B
lymphocytes, meanwhile expanded in numbers and equipped
with better receptors by affinity maturation and isotype switch-
ing in germinal centers, will be activated. What causes apoptosis
of ASCs? Ig production itself could cause death via different
mechanisms. One could be a prolonged UPR sustained by con-
tinuous Ig production. The UPR can lead to apoptosis through
multiple pathways [83–86]: activation of ER stress specific
caspases (caspase 4 in human, 12 in mouse), mitochondrial ac-
tivation by ER Ca++ release, activation of JNK via IRE1, and
suppression of anti-apoptotic bcl-2 and sensitization to ROS via
the transcription factor CHOP (downstream of the PERK branch
of the UPR) [87–96]. However, recent data exclude a role for
PERK and the downstream factor CHOP in plasma cell apo-Fig. 3. Plasma cells prepare to maintain ER and redox homeostasis before
starting massive production of Ig. Proteomic analyses of differentiating B cells
reveal a progressive up-regulation of ER resident proteins and chaperones
starting right after the differentiation stimulus, together with proteins involved in
redox homeostasis. The expression of Ig subunits (μ, L and J chains) increases
dramatically only after a few days of differentiation, concomitantly with ERp44,
ERGIC-53 and other factors involved in IgM polymerization and quality control
(adapted from [80]). To fulfil the increased oxidative demand, also Ero1α and
Ero1β accumulate, with temporal expression patterns similar to ER residents
(light blue), and IgM subunits (purple), respectively.ptosis ([74] and S. Masciarelli, L. Hendershot and R. Sitia,
unpublished results). A recent study supports a direct role of
Bax, caspase 4 and the ER in plasma cell apoptosis [97], though
autocrine or paracrine loops involving the death ligand TRAIL
may also be important [98].
In all likelihood, different factors concur in rendering ASCs
susceptible to apoptosis. One predisposing factor could be the
chaperone overload [99,100] that might arise at the high rate of
protein synthesis achieved by plasma cells. In addition, we
recently showed that in the late phases of differentiation, when
antibody production becomes maximal, proteasomal activity
decreases. This correlates with parallel increased sensitivity to
proteasome inhibitors, and stabilisation of endogenous protea-
somal substrates, including IκBα, and the proapoptotic factors
Bim and Bax [12]. Aminoacid supply and energy production
could also become limiting as Ig synthesis becomes prepon-
derant, further lowering the threshold for apoptotic commitment
[13].
Perturbation of the redox homeostasis could be yet another
factor leading to plasma cell death. On the basis of the present
knowledge about oxidative folding, the massive production and
assembly of Ig could generate abundant ROS in differentiating
plasma cells. The production of 103 IgM per second, each
containing 102 disulfides, implies that 105 bonds are formed
solely to satisfy the requirements of antibody production, ex-
plaining the increase in Ero1α and β. If O2 is the ultimate
electron acceptor also in living mammalian cells, up to 105
H2O2 molecules per second could be generated as a byproduct
of oxidative folding in IgM secreting cells.
Besides oxidative folding, additional processes could contribute
to ROS production. It has been estimated that nearly 2%of the total
oxygen consumed by mitochondria leaks from mitochondrial
respiratory chain in a partially reduced form [101]. It is reasonable
to imagine that the higher metabolic requirements in plasma cells
would cause a corresponding increase in mitochondrial ROS
generation. Such mechanism has been proposed to explain the
increase in ROS upon T lymphocytes activation ([102] and
references therein).
A regulated source of ROS in differentiating B cells could be
NADPH oxidases. These are complex enzymes known to ge-
nerate superoxide in phagocytes during inflammatory processes
[103]. Different isoforms of NADPH oxidase (NOX) and dual
oxidase (DUOX) have been described in non-phagocytic cells
to generate ROS in a regulated manner, with important conse-
quences upon signalling [104,105]. B lymphocytes express
NOX2 and DUOX1 [23,63,105]. Intriguingly, we found in-
creased expression of NOXA2 (p67phox) transcripts in murine
ASC with respect to unstimulated B lymphocytes (S. Masciar-
elli, L. Hendershot and R. Sitia, unpublished observations).
These preliminary findings deserve further analyses, especially
since previous reports failed to detect NOXA2 in plasma cells
[106].
Although formal evidence of ROS generation during plasma
cell differentiation remains to be gathered, many are the in-
dications that ASCs undergo oxidative stress. The up-regulation
of different enzymes involved in thiol redox balance upon
stimulation of I.29μ+ with LPS [80,81] has been already
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tochemistry in human plasma cells but not in B lymphocytes
infiltrating inflammatory tissue of the oral cavity, independently
of the inflammation-inducing agent [107]. An ER resident
oxidoreductase (plasma cell-Trx related protein, PC-TRP) is
specifically expressed in murine primary plasma cells [108].
Trx1 expression is higher in human cell lines with plasma cell-
like features than earlier stages of differentiation, even though
immortalized lines could be selected for stronger anti-oxidant
responses [109].
Further indication of ongoing oxidative stress in ASC comes
from the observation that differentiatingB lymphoma cells trigger
a Nrf2-dependent anti-oxidant response (S. Cozza and R. Sitia,
unpublished data). Nrf-2 is a redox-sensitive transcription factor
that mediates the induction of glutathione S-transferase,
glutamyl cysteine ligase (GCLM/GCLC, the limiting enzymes
for GSH synthesis), heme oxigenase-1 (HO-1), phase II
detoxifying enzymes and other anti-oxidant factors [110–116].
The above observations indicate that oxidative stress
[117,118] could contribute to limit plasma cell lifespan, in a
fashion possibly dependent on the rate and intensity of antibody
secretion. Proteasomal insufficiency, a chronic UPR and ROS
production could hence conjure in inducing death when enough
antibodies have been produced. It is worth recalling that the
UPR and ROS signalling share a common apoptotic pathway
through the apoptosis signal-regulated kinase 1 (ASK1) [119–
121]. Activated Ire1 recruits the TNF receptor associated factor
2 (TRAF2), which in turn binds to ASK1 leading to apoptosis
via JNK activation. ASK1 deficient cells are unable to activate
JNK and are much more resistant to ER stress-dependent death
[122]. ASK1 is negatively regulated by reduced Trx1 [123,124].
Ig synthesis could hence activate the ASK1/JNK apoptotic cas-
cade, via the different mechanisms elicited byUPR/Ire1 pathway
and ROS [124].
Furthermore, the proapototic activity of JNK is executed via
the bcl-2 family members, known to be involved in plasma cell
death. JNK can inhibit bcl-2 [125] and mcl-1 [126], and activate
Bax [127,128], Bim and Bmf [129,130]. Recent studies point to
a direct proapototic role for Bax in human plasma cells: Bax is
recruited at the ER and contributes to caspase 4 cleavage before
the release of mitochondrial apoptotic factors [97]. Bax is
stabilised and accumulates in differentiating B lymphoma cells
whilst the level of bcl-2 expression remains constant [12]. An
additional link among ER stress, ROS generation and Bax pro-
apototic activity comes from studies regarding pharmacologi-
cally induced UPR and apoptosis. The ER resident protein Bax
inhibitor 1 (BI-1) regulates ER stress associated ROS genera-
tion via up-regulation of HO-1 through Nrf-2 and protects cells
from UPR induced apoptosis [131].
Increased ROS could favour plasma cell apoptosis also
perturbing Ca++ homeostasis. The activity of both sarcoplasmic/
endoplasmic reticulum calcium ATPases (SERCA2b in parti-
cular) and IP3 Receptors type 1 are regulated in a redox depen-
dent manner [132,133]. In turn, ER Ca++ release potentiates
mitochondria-dependent apoptosis (reviewed in [25]).
Both ER stress [134,135] and ROS ([136] reviewed in [137])
were recently shown to induce autophagy. Since the latter de-gradative pathwaymay integrate proteasome function [138–141],
its stimulation by ROS and ER stress could in part compensate
proteasome impairment in ASC [12]. However, autophagy is
known to mediate caspase-independent apoptosis in response
to DNA damage [142] or cytotoxic stressors, including ROS
[143]. The role played by autophagy in the control of plasma cell
lifespan clearly deserves further investigation.
7. Concluding remarks
Terminal B lymphocyte differentiation provides a unique
system to investigate the molecular mechanisms that dynami-
cally regulate protein synthesis and secretion and lifespan cont-
rol. Several lines of evidence suggest that the production of
ROS could be exploited as a signal reporting on the protido-
synthetic efficiency within the secretory apparatus. ROS play a
key role in activation-induced apoptosis of T lymphocytes
[102,144–146]. The development of suitable imaging technol-
ogies ([147,148] and reference therein) should allow to
determine the generality of this mechanism, and its role in
limiting plasma cell lifespan.
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